ASN 2024 Poster: EL-PFDD v SONG: PKDOC, the PKD Foundation, and the ARPKD community hosted an Externally-led Patient Focused Drug Development (EL-PFDD) meeting on
NKF EL-PFDD Poster: May 2024 PKDOC, the PKD Foundation, and the ARPKD community hosted an Externally-led Patient Focused Drug Development
April 23, 2024 Clinical Outcome Assessment — Initial Public Discussion In this presentation from C-Path's rare and orphan disease program, you will see...
April 1, 2024 C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development
March 8, 2024 Rare Neurodegenerative Disease Efforts Under the ACT for ALS In this webinar from The Critical Path Institute’s Rare and Orphan Disease Program CP-RND consortium, members discuss...
January 16, 2024 C-Path weighs in on key topics to advance Real-World Data and Artificial Intelligence in Rare Diseases Vice President, Cécile Ollivier, serves on a panel of distinguished experts in the EJP RD-EFPIA Joint Advanced Webinar on...
January 30, 2024 TRxA 2024 Funding Opportunities TRxA’s focus is translating early-stage novel therapeutics into Investigational New Drug (IND) supporting data packages that...
December 8, 2023 Understanding the Role of Patient Data in Drug Development Panel within a session titled “Understanding the role of patient data in drug development” at the 2023 International...
November 16, 2023 Poster: C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development